Despite the increasing number of publications devoted to the cerebrovascular role of NO, its precise influence in awake animals is still poorly characterized. The effect of nitric oxide synthase (NOS) inhibition on the cerebrovascular CO2 reactivity was therefore studied in conscious rats. Regional CBF was measured using the [14C]iodoantipyrine technique and brain tissue sampling. The CO2 reactivity was determined 60 min after admin istration of 30 mg kg-1 NW-nitro-L-arginine methyl ester (L-NAME). Blockade of NOS by L-NAME significantly decreased CBF in all 11 brain regions studied ( -17 to Nitric oxide (NO) is a free radical gas that is in volved in a variety of biological functions including the regulation of the cerebral circulation (Moncada, 1992). A number of observations suggest that the presence of NO is essential for the preservation of resting vascular tone (see Iadecola et al., 1994, for review). Recent experimental data support also the view that NO intervenes as a mediator in some, but not all, vasodilator responses within the cerebro vascular bed. These conclusions were based on the use of L-arginine analogues that inhibit the activity of NO synthase (NOS), the enzyme that synthe sizes NO from L-arginine (Bredt et al., 1991).
-49%) and increased arterial pressure from 117 ± 12 to 147 ± 11 mm Hg. In control conditions, CO2 responsive ness ranged from 1.3 ± 0.4 in the hypophysis to 6.4 ± 0.6 mllOO g-l min-1 mm Hg-1 in the parietal cortex. Fol lowing L-NAME injection, the reactivity to hypercapnia was significantly attenuated in all structures, the magni tude of the reduction ranging from 57% in the medulla to 74% in the cerebellum. This result shows that NO is an important mediator of the hypercapnic vasodilation in the conscious rat. Key Words: Nitric oxide-Nitric oxide syn thase-NW-Nitro-L-arginine methyl ester.
tention (see Iadecola et al., 1994, for references) .
The majority of these references reported a loss of CO2 reactivity (36-94%) following administration of NOS inhibitor. However, the effects of NOS inhib itors, topically applied or intravenously injected, have been almost exclusively studied by laser Doppler flowmetry of the cortex or multiregionally using radioactive microspheres. Moreover, the an esthetics employed in these studies might interact with the endothelial as well as the neuronal NO, as previously demonstrated with volatile anesthetics (Hart et al., 1993) . The main goal of the present study was thus to examine the effect of NOS inhi bition on the regional CO2 responsiveness using a quantitative multiregional diffusible tracer tech nique in conscious animals.
MATERIALS AND METHODS
This study was conducted on 20 male Sprague-Dawley rats weighing 328 ± 42 g (Iffa Credo, Lyon, France). Anesthesia was induced with 4% halothane in a N2/02 (70:30) gas mixture and maintained with 1-1.5% halo thane. Tygon catheters were inserted into both femoral arteries and veins. The skin incisions were infiltrated with 2% lidocaine hydrochloride and were carefully sutured.
The rat was then comfortably installed in a hammock with the limbs attached underneath without excessive con straint and allowed to recover from anesthesia. Arterial pressure, heart rate, and rectal temperature were contin uously monitored and blood gases were periodically an alyzed.
Measurement of regional CBF
The CBF was measured using the [14C]iodoantipyrine technique (Sakurada et aI., 1978) combined with brain tissue sampling as previously described (Peruzzi et aI., 1993) . A solution of [14C]iodoantipyrine (20 ILCi kg-1 in 0.7 ml saline) was continuously infused for a period of 35 s. Simultaneously, 12-14 timed arterial samples (40 ILl) were collected in microtubes. The rat was killed by de capitation at the end of the infusion, and the brain was quickly removed and placed on a cool metal plate. Eleven brain regions (left and right) were dissected out and placed in preweighed vials, and the vials were reweighed. The 14C concentrations were measured by liquid scintil lation analysis in solubilized tissue and plasma samples. The absolute CBF was calculated in each brain region from the tissue sample radioactivity and the time course of the plasmatic concentration of the isotope. The brain plasma partition coefficient used for iodoantipyrine was 0.8.
Protocol
Two hours after induction of anesthesia, rats received either saline (1 ml kg -1 i. v. for 2 min) or 30 mg kg -1 N"'-nitro-L-arginine methyl ester (L-NAME; Sigma). One hour following drug injection, hypercapnia was induced in 10 rats by administering 5-10% CO2 in the inhaled N2/ O2 gas mixture through a Plexiglas dome placed around the rat's head. These rats were previously habituated to a hypercapnic test �75 min before the CBF measurement.
Statistical analysis
Since no interhemispheric difference was observed (paired Student's t test), the left and right CBF values were averaged. The effects of L-NAME administration and hypercapnia on blood gases and systemic variables were evaluated by analysis of variance and the Tukey test as a post hoc multiple comparison procedure. The effects of L-NAME administration on regional CBF were evalu ated by analysis of variance followed by Student's t test.
The regional CO2 reactivity was calculated from the slopes of the regression lines of the P aco2-CBF relation ship obtained from both normocapnic and hypercapnic animals, in the saline-(n = 10) and L-NAME-(n = 10) treated groups. The regression coefficients were ex pressed in milliliters per 100 g per minute per millimeter of mercury and compared using the Student's t test (Zar, 1984) .
RESULTS AND DISCUSSION
Intravenous injection of L-NAME (30 mg kg-I) induced a significant increase in arterial pressure with a concomitant bradycardia and no change in the other physiological parameters measured ( Table   1 ). Hypercapnia induced an increase in P a02 that reflected hyperventilation of the animals and a mod erate acidosis ( Table I) . As previously described (Macrae et aI., 1993) , the rats showed reduced mo tor activity 1 h following drug injection.
In agreement with a number of previous reports (see Iadecola et aI., 1994 , for references), we found that L-NAME markedly reduced the resting CBF in the awake rat ( Table 2) . CBF reductions ranged from -17 to -49% depending on the region stud ied, with a mean decrease of 28%. This result is very similar to that recently reported by Macrae and colleagues (1993) who found a mean CBF re duction of 30% in awake rats using the same exper imental protocol and the same CBF technique.
Moreover, these authors showed that L-NAME did not change cerebral glucose utilization and that it reduced the ratio of blood flow to metabolism.
Taken together, these data strongly suggest that NO or a related compound is critical in the tonic main tenance of resting CBF in the awake animal. The degree of regional CBF reductions was not corre lated with the regional neuronal NOS density (Bredt et aI., 1990 ) except for the hypophysis. This fact favors the implication of the endothelial rather than the neuronal NO in the tonic vasorelaxant influ ence on the cerebral circulation.
With respect to the effects of NOS inhibitors on the hypercapnia-induced vasodilation, we provide evidence, for the first time, that L-NAME strongly attenuates the CO2 reactivity in all brain regions of the awake rat. We used the slope of the regression lines of the P aco2-CBF relationship rather than the increase in flow to compare the cerebrovascular re activity to hypercapnia in both groups (saline ver sus L-NAME). This method was chosen to allow for the vasoconstrictor influence of L-NAME. To this purpose, different levels of P aco2 were tested, and as a consequence, the flow values during hypercap nia are scattered in both conditions but with a sim ilar mean PaC02 value (59.6 ± 7.8 vs. 60.7 ± 4.5 mm Hg for the saline-and the L-NAME-treated groups, respectively; see Table 2 ). From the analysis of the Paco2-CBF relationship, it appears that the data ob tained under L-NAME can be characterized by a straight regression line in all brain regions, as for the control group (Fig. 1) . Accordingly, the aver aged correlation coefficients were very high and similar, being 0.940 ± 0.073 and 0.9 12 ± 0.065 for the saline-and L-NAME-treated groups, respec tively. Thus, the attenuation of the CO2 reactivity induced by L-NAME is independent of the degree of hypercapnia, at least at Paco2 of 50--70 mm Hg. The magnitude of the attenuation ranged from 57% in the medulla and the striatum to 74% in the cere bellum ( Table 3) . This attenuation is more marked than the only value already reported for the awake rat (Sokoloff et aI., 1992) . These authors found a 38% decrease, albeit not statistically significant, of the mean hypercapnic CBF value under L-NAME, corresponding to a 49% reduction of CO2 reactivity (expressed as mllOO g-l min-1 mm Hg-1).
Recent studies have pointed out the critical im-portance of assessing NOS activity when dealing with NOS inhibitors (Irikura et aI., 1994) . In the present study, both the dose (30 mg kg -1) and the time elapsed following administration of L-NAME (60 min) have been shown to be appropriate to in duce a marked inhibition of NOS in the rat brain (see Iadecola et aI., 1994, for references) . For in stance, it has been reported that the CBF reduction induced by 30--40 mg kg-1 L-NAME (Macrae et aI., 1993) as well as the attenuation of the cerebrova sodilation elicited by hypercapnia (Iadecola and Zhang, 1994) are almost maximal 60 min after intra venous injection. So, we can reasonably assume that our data represent the optimal effect of L-NAME on the cerebrovascular reactivity. Al though our study definitively implies NO in the ce rebrovascular reactivity to CO2 in conscious rats, it seems unlikely that NO accounts for the whole hy percapnic vasodilation. The hypercapnic response is also markedly attenuated by the cyclooxygenase inhibitor indomethacin (Iadecola, 1992; Wang et al., 1993) and is not affected by NOS inhibitors at PaC02 exceeding lOO mm Hg (Iadecola and Zhang, 1994) , two facts that support the existence of NO independent components in the cerebrovascular re sponse to hypercapnia.
Concerning the source(s) of NO in hypercapnia, no definitive conclusion has yet been presented.
Our results show that the effects of L-NAME on the cerebrovascular CO2 responsiveness were fairly ho mogeneous in the brain. Nevertheless, it should be emphasized that the lowest attenuation of CO2 re activity, among the regions analyzed, was in the medulla ( -57%), the region that contains the least NOS activity. The largest attenuation of reactivity was noted in the cerebellum (-74%), where the highest NOS activity has been detected (Forster mann et aI., 1990) . These data support the contri- cortex, and cerebellum, both in control conditions and following 30 mg kg-1 N"'-nitro-L'arginine methyl ester (L-NAME) admin istration. The slopes of these regression lines (corresponding to the CO2 reactivity) are statistically significant between control and L-NAME conditions in all four brain regions.
bution of multiple sources of NO, endothelial NO being possibly involved, since a decrease of the CO2 reactivity was also observed in the medulla, a struc ture devoid of NOS-positive neurons. TABLE 3. Effects ofN"'-nitro-L-arginine methyl ester (L-NAME) on regional CO2 reactivity (ml JOO g-l min-1 mm Hg-1)
CO2 reactivity
Saline L-NAME % changea Values are expressed as means ± SD (n = 10 in each group). a (Saline.L-NAME)/saline X 100.
b P < 0.05, cp < 0.001 (comparison of the slopes using Stu dent's t test).
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